Are MUSE cells for real? Stem cells come in different types that vary in a key property called “potency”, but very few are pluripotent. The more potency, the greater the flexibility of a stem cell to make other cell types. Flexibility in the cellular world is power. The most powerful stem cells generally used are …
Jury is still out on purported adult pluripotent stem cells despite new MUSE paper Read More »
Remember the electric StemCell Bra? This innovation is hoped by the creators to grow bigger breasts for women via the power of electricity and stem cells. Could this work? How would it work? Is it safe? Are there clinical trials ongoing? Who is the team and what is the rationale behind this technology? I’ve emailed …
The StemCell Bra interview with Howard Leonhardt Read More »
One of the more exciting stem cell biotechs out there today is Advanced Cell Technology (ACT). At this time ACT has the only two ES cell-based FDA-approved clinical trials ongoing and so far they have looked quite promising in terms of preliminary safety data. However, ACT has much more in the pipeline including potentially iPS …
Interview with Gary Rabin of Advanced Cell Technology (ACT) Read More »
CIRM recently held an “elevator pitch” (also sometimes known as an “elevator speech”) contest amongst its grantees. The San Francisco Chronicle even covered this contest (and also here). Kevin McCormack, Sr. Director of Public Communications and Patient Advocate Outreach at CIRM, described the contest in, appropriately enough, a speech. As best as I can tell 56 scientists participated. By way …
Over the last few weeks, I have enjoyed talking with and interviewing Dr. Allan Wu, of The Morrow Institute on stem cell cosmetic procedures. I was impressed greatly by his talk at the World Stem Cell Summit last year. Dr. Wu is a fellowship trained Surgical Molecular Biologist with a background in Molecular Embryology and a board …
Interview with Regenerative Surgeon, Dr. Allan Wu Read More »
Who reads this blog? A bunch of cool people including in science, educators, reporters, and patient advocates around the world. Some of them contact me, almost always to say nice things. Sometimes not so nice. To my knowledge this blog remains the only one in the world on stem cells written by a faculty level …
I have posted before about publishing trends in the iPS cell field here and in here…. but where do things stand today? Here, I provide an important update. What’s going on now? Here I provide answers to the key questions. How many papers are there on iPS cells? An interesting and unexpected trend for this …
Everything you need to know about publishing in the iPS cell field Read More »
Advanced Cell Technology (ACT) announced today that it has treated two patients in its clinical trials: one for Stargardt’s Macular Dystrophy (see official trial page for a lot more info) and one for Dry Age-Related Macular Degeneration (see official trial page here for a lot more info). The patients underwent the treatment at UCLA and each …
There has been a largely media-fed hullabaloo about the salary for the new Chair of CIRM, the California Institute for Regenerative Medicine, $400,000. Now don’t get me wrong, that sounds like a lot of money to me personally, but we need to put it in perspective and when we do, the salary is reasonable and …
California pays its sports coaches alone more than the entire payroll of CIRM Read More »
CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company …
CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »